Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma

Figure 2

cancer-specific survival curves of enrolled GBM cohort. The cancer-specific survival (CSS) of GBM patients were analyzed according to patients’ age (a), sex (b), tumor location (c), tumor size (d), surgery pattern (e), adjuvant chemotherapy (f), and RBP4 protein expression in tumor tissues (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)